D.Z. Mijin et al. / Dyes and Pigments 85 (2010) 73e78
75
2.40 (s, 3H, CH3). 13C NMR (75 MHz, DMSO-d6)
162.1, 151.7, 148.2, 132.9, 132.5, 131.5, 120.2, 118.5, 96.2, 25.5, 19.9,
d
(ppm) ¼ 170.3,
2.2.12. 5-((4-Bromo-2,6-dimethylphenyl)diazenyl)-6-hydroxy-4-
methyl-2-oxo-1,2-dihydropyridine-3-carbonitrile (5c)
19.4. UVevis (ethanol): lmax/nm: [(log
3)]: 458 (3.19), 355 (4.22).
Orange powder, Mp >300 ꢂC. 1H NMR (300 MHz, DMSO-d6)
(ppm) ¼ 13.96 (s, 1H, NH), 7.21 (s, 2 H, Ar-H), 2.33 (s, 6 H, 2 CH3),
MS (neg. APCI) m/z: 358.1 [M - Hþ], (M ¼ 359.2).
d
2.22 (s, 3 H, CH3). 13C NMR (75 MHz, DMSO-d6)
d
(ppm) ¼ 196.9,
2.2.6. 4,6-Dimethyl-5-((2-nitrophenyl)diazenyl)-2-oxo-1,2-
dihydropyridine-3-carbonitrile (1f)
164.7, 163.5, 139.9, 132.0, 131.7, 131.1, 129.4, 126.6, 113.9, 27.4, 19.7.
UVevis (ethanol): lmax/nm: [(log 3)]: 432 (3.62), 350 (4.08). MS
Orange powder, Mp >300 ꢂC. 1H NMR (300 MHz, DMSO-d6)
(neg. APCI) m/z: 360.1 [M - Hþ], (M ¼ 361.1).
d
(ppm) ¼ 7.87 (d, J ¼ 13.8 Hz, 1 H, Ar-H), 7.67e7.69 (m, 2 H, Ar-H),
7.43e7.49 (m, 1 H, Ar-H), 2.48 (s, 3 H, CH3), 2.44 (s, 3 H, CH3). 13
NMR (75 MHz, DMSO-d6)
(ppm) ¼ 170.5, 164.1, 149.8, 147.2, 146.1,
C
2.2.13. 5-((4-Bromophenyl)diazenyl)-6-hydroxy-4-methyl-2-oxo-
1,2-dihydropyridine-3-carbonitrile (5d)
d
133.0, 128.1, 123.7, 119.5, 118.4, 97.4, 25.4, 19.8. UVevis (ethanol):
Orange powder, Mp >300 ꢂC. 1H NMR (300 MHz, DMSO-d6)
lmax/nm: [(log
3
)]: 385 (4.19). MS (pos. APCI) m/z: 298.1 [M þ Hþ],
d
(ppm) ¼ 13.74 (s, 1H, NH)/10.26* (s, 1H, NH), 7.57* (d, J ¼ 9 Hz, 2 H,
MS (neg. APCI) m/z: 296.1 [M - Hþ], (M ¼ 297.2).
Ar-H), 7.46* (d, J ¼ 9 Hz, 2 H, Ar-H), 7.44 (d, J ¼ 9 Hz, 2 H, Ar-H), 7.16
(d, J ¼ 9 Hz, 2 H, Ar-H), 2.51* (s, 3 H, CH3)/2.13 (s, 3 H, CH3),
(tautomeric ratio, %: 5d/5d* ¼ 62:38). UVevis (ethanol): lmax/nm:
2.2.7. 5-((2,6-Dimethylphenyl)diazenyl)-2-oxo-4,6-diphenyl-1,2-
dihydropyridine-3-carbonitrile (1g)
[(log
3
)]: 348 (3.69). MS (neg. APCI) m/z: 329.1 [M - Hþ], (M ¼ 333.1).
Red solid, Mp 161e162 ꢂC. 1H NMR (300 MHz, DMSO-d6)
d
(ppm) ¼ 7.42e7.45 (m, 1 H, Ar-H), 7.26e7.36 (m, 8 H, Ar-H),
6.80e6.82 (m, 2 H, Ar-H), 2.48 (s, 3 H, CH3), 1.62 (s, 6 H, 2 CH3). 13
NMR (75 MHz, DMSO-d6)
(ppm) ¼ 170.0, 161.8, 150.4, 149.9, 142.0,
139.1, 132.6, 131.0, 129.8, 129.1, 128.7, 128.2, 127.6, 127.5, 127.4, 127.2,
2.2.14. 6-Hydroxy-2-oxo-4-phenyl-5-(phenyldiazenyl)-1,2-
dihydropyridine-3-carbonitrile (5e)
C
d
Orange powder, Mp >300 ꢂC. 1H NMR (300 MHz, DMSO-d6)
d
(ppm) ¼ 13.96 (s, 1H, NH), 7.82 (d, J ¼ 6.9 Hz, 2 H, Ar-H), 7.57 (t,
119.8, 96.4,19.1. UVevis (ethanol): lmax/nm: [(log
3
)]: 367 (4.13). MS
J ¼ 7.5 Hz,1 H, Ar-H), 7.47 (t, J ¼ 7.5 Hz, 2 H, Ar-H), 7.19e7.24 (m, 2 H,
(pos. APCI) m/z: 405.2 [M þ Hþ], MS (neg. APCI) m/z: 403.2 [M - Hþ],
(M ¼ 404.4).
Ar-H), 6.99 (d, J ¼ 7.5 Hz, 2 H, Ar-H), 6.81 (t, J ¼ 7.5 Hz, 1 H, Ar-H). 13C
NMR (75 MHz, DMSO-d6)
d
(ppm) ¼ 193.4, 165.6, 144.3,140.6, 138.6,
132.5, 129.7, 128.4, 120.7, 113.3. UVevis (ethanol): lmax/nm: [(log
2.2.8. 2-Oxo-4,6-diphenyl-5-(phenyldiazenyl)-1,2-dihydropyridine-
3-carbonitrile (1h)
3
)]: 360 (4.24). MS (pos. APCI) m/z: 318.9 [M þ Hþ], MS (neg. APCI)
m/z: 315.1 [M - Hþ], (M ¼ 316.3).
Yellow powder, Mp 190e192 ꢂC (dec). 1H NMR (300 MHz,
DMSO-d6)
Ar-H), 7.18e7.26 (m, 5 H, Ar-H), 6.89e6.92 (m, 2 H, Ar-H). 13C NMR
(75 MHz, DMSO-d6)
(ppm) ¼ 170.2, 161.8, 152.7, 149.0, 141.3, 138.8,
131.5, 130.5, 129.2, 129.1, 128.9, 128.0, 127.4, 121.4, 119.9, 96.7.
d
(ppm) ¼ 7.47e7.50 (m, 2 H, Ar-H), 7.33e7.35 (m, 6 H,
3. Results and discussion
d
As a starting point for our investigation, we examined the
synthesis of 5-phenylazo-4,6-dimethyl-3-cyano-2-pyridone (1a)
from phenylazo acetylacetone (2a) and cyanoacetamide (3), using
KOH as the base for the reaction (Scheme 2, Table 1) in ethanol as
the solvent. The use of KOH instead of the previously employed
sodium ethoxide [17,18] was found to be more convenient. All
studies were performed applying controlled single-mode micro-
wave heating in sealed vessels [20,21]. Screening of reaction
conditions focused on different amounts of the KOH, amide, and
variations in reaction time and temperature. As can be seen in
Table 1 among different temperatures a better result was obtained
at 130 ꢂC (entries 1e8). The effect of the molar excess of amide 3
was checked and it was found that in the presence of 2 equivalents
of the amide an optimum result was obtained (Table 1, entries
9e13). Running the reaction for different periods of times (Table 1,
entries 13e16), revealed that complete conversions were generally
UVevis (ethanol): lmax/nm: [(log 3)]: 370 (4.01). MS (pos. APCI) m/
z: 377.5 [M þ Hþ], MS (neg. APCI) m/z: 375.6 [M - Hþ], (M ¼ 376.4).
2.2.9. 5-((4-Bromo-2,6-dimethylphenyl)diazenyl)-2-oxo-4,6-
diphenyl-1,2-dihydropyridine-3-carbonitrile (1i)
Dark red solid, Mp 179e180 ꢂC. 1H NMR (300 MHz, DMSO-d6)
d
(ppm) ¼ 7.41e7.44 (m, 2 H, Ar-H), 7.26e7.34 (m, 8 H, Ar-H), 7.03 (s,
2 H, Ar-H), 1.58 (s, 6 H, 2 CH3). 13C NMR (75 MHz, DMSO-d6)
(ppm) ¼ 169.9, 162.2, 150.0, 149.3, 141.9, 139.0, 133.7, 132.5, 131.4,
129.8, 128.7, 128.3, 127.6, 127.6, 127.4, 119.7, 119.6, 96.7, 18.8. UVevis
d
(ethanol): lmax/nm: [(log
3)]: 374 (4.08). MS (neg. APCI) m/z: 482.2
[M - Hþ], (M ¼ 483.4).
2.2.10. 6-Hydroxy-4-methyl-2-oxo-5-(phenyldiazenyl)-1,2-
dihydropyridine-3-carbonitrile (5a)
Orange powder, Mp >300 ꢂC (Lit. Mp 288e289 ꢂC [8]). 1H NMR
(300 MHz, DMSO-d6)
d
(ppm) ¼ 13.74 (s, 1H, NH)/10.17* (s, 1H, NH),
7.54 (d, J ¼ 7.2 Hz, 2H, Ar-H), 7.40 (t, J ¼ 7.5 Hz, 2 H, Ar-H), 7.17*-7.32*
(m, 5 H, Ar-H), 6.91 (t, J ¼ 7.2 Hz, 1 H, Ar-H), 2.51* (s, 3 H, CH3)/2.32
(s, 3 H, CH3) (tautomeric ratio, %: 5a/5a* ¼ 50:50). UVevis
(ethanol): lmax/nm: [(log 3)]: 430 (4.19), 353 (4.19). MS (neg. APCI)
m/z: 253.2 [M - Hþ], (M ¼ 254.2).
2.2.11. 5-((2,6-Dimethylphenyl)diazenyl)-6-hydroxy-4-methyl-2-
oxo-1,2-dihydropyridine-3-carbonitrile (5b)
Orange powder, Mp >300 ꢂC. 1H NMR (300 MHz, DMSO-d6)
d
(ppm) ¼ 14.23 (s, 1 H, NH), 7.02 (d, J ¼ 7.5 Hz, 2 H, Ar-H), 6.85 (t,
J ¼ 7.5 Hz, 1H, Ar-H), 2.34 (s, 6 H, 2 CH3), 2.23 (s, 3 H, CH3). 13C
NMR (75 MHz, DMSO-d6)
138.1, 129.6, 129.1, 128.8, 127.3, 123.0, 27.3, 20.0. UVevis (ethanol):
lmax/nm: [(log
(M ¼ 282.3).
d
(ppm) ¼ 197.2, 165.4, 156.1, 140.2,
3
)]: 412 (4.06). MS (neg. APCI) m/z: 281 [M - Hþ],
Scheme 2.